Salvianolic acid B attenuates rat hepatic fibrosis via downregulating angiotensin II signaling

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Li, Shu ^a   Wang, Lina ^a,b   Yan, Xiuchuan ^a   Wang, Qinglan ^a   Tao, Yanyan ^a   Li, Junxia ^a   Peng, Yuan ^a   Liu, Ping ^a,c,d   Liu, Chenghai ^a,c,d  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Shanghai Key Laboratory of Traditional Chinese Clinical Medicine   (China)

^d Shanghai Municipal Education Commission   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN 1 RECEPTOR; COLLAGEN TYPE 1; DIMETHYLNITROSAMINE DEMETHYLASE; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; PERINDOPRIL; PROTEIN C JUN; SALVIANOLIC ACID B; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; STELLATE CELL;

EID: 84871423288     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/160726     Document Type: Article

References (45)

1. Roskams T., Relationships among stellate cell activation, progenitor cells, and hepatic regeneration. Clinics in Liver Disease 2008 12 4 853 860 2-s2.0-54549093685 10.1016/j.cld.2008.07.014
2. Moreira R. K., Hepatic stellate cells and liver fibrosis. Archives of Pathology and Laboratory Medicine 2007 131 11 1728 1734 2-s2.0-35948964347 (Pubitemid 350077474)
3. Das S. K., Vasudevan D. M., Genesis of hepatic fibrosis and its biochemical markers. Scandinavian Journal of Clinical and Laboratory Investigation 2008 68 4 260 269 2-s2.0-46949105856 10.1080/00365510701668516 (Pubitemid 351962407)
4. Paizis G., Gilbert R. E., Cooper M. E., Murthi P., Schembri J. M., Wu L. L., Rumble J. R., Kelly D. J., Tikellis C., Cox A., Smallwood R. A., Angus P. W., Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. Journal of Hepatology 2001 35 3 376 385 2-s2.0-0034849945 10.1016/S0168-8278(01)00146-5 (Pubitemid 32844192)
5. Jonsson J. R., Clouston A. D., Ando Y., Kelemen L. I., Horn M. J., Adamson M. D., Purdie D. M., Powell E. E., Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 2001 121 1 148 155 2-s2.0-0034961836 (Pubitemid 32591525)
6. Yoshiji H., Kuriyama S., Yoshii J., Ikenaka Y., Noguchi R., Nakatani T., Tsujinoue H., Fukui H., Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 2001 34 4 745 750 2-s2.0-0034802566 10.1053/jhep.2001.28231 (Pubitemid 32927999)
7. Bataller R., Ginès P., Nicolás J. M., Görbig M. N., GarciaRamallo E., Gasull X., Bosch J., Arroyo V., Rodés J., Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 2000 118 6 1149 1156 2-s2.0-0034120267 (Pubitemid 30346992)
8. Bataller R., Sancho-Bru P., Ginès P., Lora J. M., Al-Garawi A., Solé M., Colmenero J., Nicolás J. M., Jiménez W., Weich N., Gutiérrez-Ramos J. C., Arroyo V., Rodés J., Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 2003 125 1 117 125 2-s2.0-0037772442 10.1016/S0016-5085(03)00695-4 (Pubitemid 36799113)
9. Paizis G., Cooper M. E., Schembri J. M., Tikellis C., Burrell L. M., Angus P. W., Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 2002 123 5 1667 1676 2-s2.0-0036830185 (Pubitemid 35231666)
10. Bataller R., Gäbele E., Schoonhoven R., Morris T., Lehnert M., Yang L., Brenner D. A., Rippe R. A., Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver. American Journal of Physiology-Gastrointestinal and Liver Physiology 2003 285 3 G642 G651 2-s2.0-0042009848 (Pubitemid 37021824)
11. Powell E. E., Edwards-Smith C. J., Hay J. L., Clouston A. D., Crawford D. H., Shorthouse C., Purdie D. M., Jonsson J. R., Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000 31 4 828 833 2-s2.0-0034024356 (Pubitemid 30169926)
12. Li X., Meng Y., Wu P., Zhang Z., Yang X., Angiotensin II and Aldosterone stimulating NF- B and AP-1 activation in hepatic fibrosis of rat. Regulatory Peptides 2007 138 1 15 25 2-s2.0-33845476271 10.1016/j.regpep.2006.07.011 (Pubitemid 44918126)
13. Yang L., Bataller R., Dulyx J., Coffman T. M., Ginès P., Rippe R. A., Brenner D. A., Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. Journal of Hepatology 2005 43 2 317 323 2-s2.0-21844457440 10.1016/j.jhep.2005.02.034 (Pubitemid 40956886)
14. Wang X. N., Hu Y. Y., Liu C. H., Liu P., Zhu D. Y., Effects of salvianolic acid B on expressions of TGF-beta1 and its receptors in liver of rats with dimethylnitrosamine-induced hepatic fibrosis. Zhong Xi Yi Jie He Xue Bao 2005 3 4 286 289 2-s2.0-33645085904
15. Bataller R., Brenner D. A., Liver fibrosis. Journal of Clinical Investigation 2005 115 2 209 218 2-s2.0-14944385607 10.1172/JCI200524282 (Pubitemid 40385459)
16. Marshall R. P., McAnulty R. J., Laurent G. J., Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. American Journal of Respiratory and Critical Care Medicine 2000 161 6 1999 2004 2-s2.0-0034047028 (Pubitemid 30418143)
17. Douillette A., Bibeau-Poirier A., Gravel S. P., Clément J. F., Chénard V., Moreau P., Servant M. J., The proinflammatory actions of angiotensin II are dependent on p65 phosphorylation by the I B kinase complex. Journal of Biological Chemistry 2006 281 19 13275 13284 2-s2.0-33744953674 10.1074/jbc.M512815200 (Pubitemid 43855239)
18. Ruiz-Ortega M., Lorenzo O., Rupérez M., Suzuki Y., Egido J., Angiotensin II activates nuclear transcription factor- B in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice. Nephrology Dialysis Transplantation 2001 16 supplement 1 27 33 2-s2.0-0035017387 (Pubitemid 32492501)
19. Jin H., Yamamoto N., Uchida K., Terai S., Sakaida I., Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient l-amino acid-defined diet. Biochemical and Biophysical Research Communications 2007 364 4 801 807 2-s2.0-36148979351 10.1016/j.bbrc.2007.10.083 (Pubitemid 350103697)
20. Yu F. J., Dong P. H., Fan X. F., Lin Z., Chen Y. P., Li J., Down-regulation of angiotensin II by shRNA reduces collagen synthesis in hepatic stellate cells. International Journal of Molecular Medicine 2010 25 5 801 806 2-s2.0-77951730492 10.3892/ijmm-00000407
21. Hirose A., Ono M., Saibara T., Nozaki Y., Masuda K., Yoshioka A., Takahashi M., Akisawa N., Iwasaki S., Oben J. A., Onishi S., Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology 2007 45 6 1375 1381 2-s2.0-34250323865 10.1002/hep.21638 (Pubitemid 46918321)
22. Nabeshima Y., Tazuma S., Kanno K., Hyogo H., Iwai M., Horiuchi M., Chayama K., Anti-fibrogenic function of angiotensin II type 2 receptor in CCl 4-induced liver fibrosis. Biochemical and Biophysical Research Communications 2006 346 3 658 664 2-s2.0-33745204406 10.1016/j.bbrc.2006.05.183
23. 4 Biochemical and Biophysical Research Communications 2003 308 1 177 183 2-s2.0-0041347547 10.1016/S0006-291X(03)01357-3 (Pubitemid 36904138)
24. Rockey D. C., Current and future anti-fibrotic therapies for chronic liver disease. Clinics in Liver Disease 2008 12 4 939 962 2-s2.0-54549119172 10.1016/j.cld.2008.07.011
25. Liu P., Hu Y. Y., Liu C., Xu L. M., Liu C. H., Sun K. W., Hu D. C., Yin Y. K., Zhou X. Q., Wan M. B., Cai X., Zhang Z. Q., Ye J., Zhou R. X., He J., Tang B. Z., Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B. World Journal of Gastroenterology 2005 11 19 2892 2899 2-s2.0-20344397684 (Pubitemid 40790056)
26. Liu C., Jiang C. M., Liu C. H., Liu P., Hu Y. Y., Effect for Fuzhenghuayu decoction on vascular endothelial growth factor secretion in hepatic stellate cells. Hepatobiliary and Pancreatic Diseases International 2002 1 2 207 210 2-s2.0-0038544518 (Pubitemid 36748203)
27. Liu C., Liu P., Liu C. H., Zhu X. Q., Ji G., Effects of Fuzhenghuayu decoction on collagen synthesis of cultured hepatic stellate cells, hepatocytes and fibroblasts in rats. World Journal of Gastroenterology 1998 4 6 548 549 2-s2.0-0001972926 (Pubitemid 128620236)
28. Liu C., Jiang C., Liu C., Liu P., Hu Y., Intervention of Fuzhenghuayu decoction on autocrine activation of hepatic stellate cells. Zhonghua Gan Zang Bing Za Zhi 2001 9 5 282 284 2-s2.0-0035491236
29. Liu P., Hu Y. Y., Liu C., Zhu D. Y., Xue H. M., Xu Z. Q., Xu L. M., Liu C. H., Gu H. T., Zhang Z. Q., Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World Journal of Gastroenterology 2002 8 4 679 685 2-s2.0-0036678553 (Pubitemid 34918663)
30. Wang L., Tao Y., Li S., Chen G., Liu C., Effects of salvianolic acid B on lipid peroxidation and metalloproteinase-2 activity in fibrotic liver in rat. Zhongguo Zhongyao Zazhi 2010 35 1 71 75 2-s2.0-77951218199 10.4268/cjcmm20100115
31. Friedman S. L., Rockey D. C., McGuire R. F., Maher J. J., Boyles J. K., Yamasaki G., Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology 1992 15 2 234 243 2-s2.0-0026537533
32. Sohail M. A., Hashmi A. Z., Hakim W., Watanabe A., Zipprich A., Groszmann R. J., Dranoff J. A., Torok N. J., Mehal W. Z., Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition. Hepatology 2009 49 1 185 194 2-s2.0-58949088374 10.1002/hep.22589
33. Moreno M., Ramalho L. N., Sancho-Bru P., Ruiz-Ortega M., Ramalho F., Abraldes J. G., Colmenero J., Dominguez M., Egido J., Arroyo V., Ginès P., Bataller R., Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver. American Journal of Physiology-Gastrointestinal and Liver Physiology 2009 296 2 G147 G156 2-s2.0-59449095024 10.1152/ajpgi.00462.2007
34. 2+ signaling contributes to angiotensin II-induced activation of hepatic stellate cells: attenuation of hepatic fibrosis by CD38 ablation. Journal of Biological Chemistry 2010 285 1 576 582 2-s2.0-73649108888 10.1074/jbc.M109.076216
35. Wang L., liu C., Chen Y., Tao Y., Zhou T., Cheng G. A., Modified methed to create rat model of hepatic fibrosis with dimethylnitrosamine and its pathological characteristics. Acta Laroratorium Animalis Scientia Sinca 2007 17 2 90 94
36. Vogel S., Piantedosi R., Frank J., Lalazar A., Rockey D. C., Friedman S. L., Blaner W. S., An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. Journal of Lipid Research 2000 41 6 882 893 2-s2.0-0033921113 (Pubitemid 30434319)
37. Liu J., Gong H., Zhang Z. T., Wang Y., Effect of angiotensin II and angiotensin II type 1 receptor antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells. Chinese Medical Journal 2008 121 2 161 165 2-s2.0-39049109292 (Pubitemid 351247891)
38. 4 World Journal of Gastroenterology 2000 6 6 824 828 2-s2.0-0034529716 (Pubitemid 32015797)
39. Moreno-Alvarez P., Sosa-Garrocho M., Briones-Orta M. A., González-Espinosa C. G., Medina-Tamayo J., Molina-Jijón E., Pedraza-Chaverri J., Macías-Silva M., Angiotensin II increases mRNA levels of all TGF- β isoforms in quiescent and activated rat hepatic stellate cells. Cell Biology International 2010 34 10 969 978 2-s2.0-77957348899 10.1042/CBI20090074
40. Lv Z., Song Y., Xue D., Zhang W., Cheng Y., Xu L., Effect of Salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor- β 1 in activated rat hepatic stellate cells. Journal of Ethnopharmacology 2010 132 2 384 392 2-s2.0-78049382168 10.1016/j.jep.2010.05. 026
41. Schaeffer H. J., Weber M. J., Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Molecular and Cellular Biology 1999 19 4 2435 2444 2-s2.0-0032935664 (Pubitemid 29144487)
42. Johnson G. L., Lapadat R., Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002 298 5600 1911 1912 2-s2.0-0037032817 10.1126/science.1072682 (Pubitemid 35425238)
43. Wada T., Penninger J. M., Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004 23 16 2838 2849 2-s2.0-2342562556 10.1038/sj.onc. 1207556 (Pubitemid 38638846)
44. Chang F., Steelman L. S., Lee J. T., Shelton J. G., Navolanic P. M., Blalock W. L., Franklin R. A., McCubrey J. A., Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 2003 17 7 1263 1293 2-s2.0-0037810249 10.1038/sj.leu.2402945 (Pubitemid 36857335)
45. Vogt P. K., Jun, the oncoprotein. Oncogene 2001 20 19 2365 2377 2-s2.0-0035971506 10.1038/sj.onc.1204443 (Pubitemid 32531295)